REQSX
Price
$23.34
Change
+$0.09 (+0.39%)
Updated
Jul 25 closing price
Net Assets
164.31M
VIVAX
Price
$70.47
Change
+$0.29 (+0.41%)
Updated
Jul 25 closing price
Net Assets
195.18B
Interact to see
Advertisement

REQSX vs VIVAX

Header iconREQSX vs VIVAX Comparison
Open Charts REQSX vs VIVAXBanner chart's image
Russell Inv Equity Income C
Price$23.34
Change+$0.09 (+0.39%)
VolumeN/A
Net Assets164.31M
Vanguard Value Index I
Price$70.47
Change+$0.29 (+0.41%)
VolumeN/A
Net Assets195.18B
REQSX vs VIVAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
REQSX vs. VIVAX commentary
Jul 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is REQSX is a Buy and VIVAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIVAX has more cash in the bank: 195B vs. REQSX (164M). VIVAX pays higher dividends than REQSX: VIVAX (2.06) vs REQSX (1.20). REQSX was incepted earlier than VIVAX: REQSX (17 years) vs VIVAX (33 years). REQSX (1.95) is less costly to investors than VIVAX (0.17). REQSX is a more actively managed with annual turnover of: 35.00 vs. VIVAX (9.00). REQSX has a lower initial minimum investment than VIVAX: REQSX (0) vs VIVAX (3000). VIVAX annual gain was more profitable for investors over the last year : 9.76 vs. REQSX (-2.50). VIVAX return over 5 years is better than : 74.87 vs. REQSX (4.42).
REQSXVIVAXREQSX / VIVAX
Total Expense Ratio1.870.171,100%
Annual Report Gross Expense Ratio1.950.171,147%
Fund Existence17 years33 years-
Gain YTD8.2316.724122%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets164M195B0%
Annual Yield % from dividends1.202.0658%
Returns for 1 year-2.509.76-26%
Returns for 3 years-10.1134.31-29%
Returns for 5 years4.4274.876%
Returns for 10 years-37.66116.32-32%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CDGRX12.890.08
+0.62%
Copeland Dividend Growth Fund Class A
MSRRX59.330.25
+0.42%
MFS Research R2
EQNTX23.150.08
+0.35%
MFS Equity Income R3
BMCIX29.320.01
+0.03%
BlackRock High Equity Income Instl
MASGX13.46-0.13
-0.96%
Matthews Emerging Markets Sust Fut Inv